Hemodynamic resuscitation with fluids bolus and norepinephrine increases severity of lung damage in an experimental model of septic shock

Objective: Hemodynamic resuscitation is considered a cornerstone of the initial treatment of septic shock. However, there is growing concern about its side effects. Our objective was to assess the relationship between fluid administration and norepinephrine infusion and the development of lung injury. Design: Randomized in vivo study in rabbits. Setting: University animal research laboratory. Patients: Eighteen New Zealand rabbits. Control group (SHAM, n = 6), Sepsis group with or without hemodynamic resuscitation (ETX-R, n = 6; ETX-NR, n = 6). Interventions: Sepsis was induced by intravenous lipopolysaccharide administration and animals were followed-up for 4 h. Hemodynamic resuscitation with Ringer lactate (20 mL.kg(-1)) was administered and later norepinephrine was initiated 3 h after sepsis induction. At the end, the left lung was excised. Main variables of interest: An indwelling arterial catheter and an esophageal Doppler were placed. Lung mechanics were monitored with side stream spirometry. Lung damage was analyzed by histopathological examination. Results: The SHAM group did not show hemodynamic or respiratory changes. Lipopolysaccharide administration aimed an increase in cardiac output and arterial hypotension. In the ETX-NR group, animals remained hypotensive until the end of the experiment. Resuscitation with fluids and norepinephrine reversed arterial hypotension. Compared to the ETX-NR group, the remaining lung of the ETX-R group showed greater accumulation of neutrophils and reactive type-II pneumocytes, thicker alveolar wall, alveolar hemorrhage and non-aerated pulmonary areas. Lung injury score was larger in the ETX-R group. Conclusions: In our experimental study, following a strategy with bolus fluids and late norepinephrine used in the early phase of endotoxic septic shock has a negative influence on the development of lung injury. (C) 2020 Elsevier Espana, S.L.U. y SEMICYUC. All rights reserved.